Please Wait
Applying Filters...
menu
    • menu
    J&J’s Intra‑Cellular buyout, BMS’ oncology gambit, Sanofi’s Blueprint acquisition drive mega deals in H1 2025

    Data Compilation
    #PharmaFlow

    Pipeline Prospector June 2025: Sanofi, AbbVie, Eli Lilly, BioNTech lead pharma M&A spree; BMS, Astra ink major collaborations

    Stock Recap
    #PipelineProspector

    Menu

    Desloratadine [USAN]

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,028Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to access your PharmaMiles and download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    28/06/2025 Divis Laboratories
    India
    		 Parmarine Co., Ltd. 20241230-179-I-689-05 Undifferentiated desloratadine 2024-12-30 Divi's Laboratories Ltd. India Unit-1, Lingojigudem Village Choutuppal Mandal Yadadri Bhuvanagiri District Telangana - 508252 India
    28/06/2025 Merck & Co
    U.S.A
    		 Korea Organon Co., Ltd. 20200402-179-I-602-04 Desloratadine 2020-04-02 MSD International GmbH(Singapore Branch)@Rolabo Outsourcing, SL U.S.A 50 Tuas West Drive Singapore 638408@Polígono Malpica Calle J No. 3-450016 Zaragoza Spain